BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21732276)

  • 1. Evolution of angiogenesis.
    Muñoz-Chápuli R
    Int J Dev Biol; 2011; 55(4-5):345-51. PubMed ID: 21732276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factors: A comparison between invertebrates and vertebrates.
    Kipryushina YO; Yakovlev KV; Odintsova NA
    Cytokine Growth Factor Rev; 2015 Dec; 26(6):687-95. PubMed ID: 26066416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of VEGF signalling output by the Notch pathway.
    Siekmann AF; Covassin L; Lawson ND
    Bioessays; 2008 Apr; 30(4):303-13. PubMed ID: 18348190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis.
    Lohela M; Bry M; Tammela T; Alitalo K
    Curr Opin Cell Biol; 2009 Apr; 21(2):154-65. PubMed ID: 19230644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of FGF and VEGF in angioblast induction and migration during vascular development.
    Poole TJ; Finkelstein EB; Cox CM
    Dev Dyn; 2001 Jan; 220(1):1-17. PubMed ID: 11146503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGFRs and Notch: a dynamic collaboration in vascular patterning.
    Jakobsson L; Bentley K; Gerhardt H
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1233-6. PubMed ID: 19909253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions.
    Takahashi H; Shibuya M
    Clin Sci (Lond); 2005 Sep; 109(3):227-41. PubMed ID: 16104843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
    Pradeep CR; Sunila ES; Kuttan G
    Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Angiogenesis under Delta-Notch couple control].
    Suchting S; Freitas C; Eichmann A
    Med Sci (Paris); 2007 Apr; 23(4):347-8. PubMed ID: 17433219
    [No Abstract]   [Full Text] [Related]  

  • 11. To sprout or to split? VEGF, Notch and vascular morphogenesis.
    Gianni-Barrera R; Trani M; Reginato S; Banfi A
    Biochem Soc Trans; 2011 Dec; 39(6):1644-8. PubMed ID: 22103501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular regeneration and angiogenic-like sprouting mechanism in a compound ascidian is similar to vertebrates.
    Gasparini F; Burighel P; Manni L; Zaniolo G
    Evol Dev; 2008; 10(5):591-605. PubMed ID: 18803777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.
    Hicklin DJ; Ellis LM
    J Clin Oncol; 2005 Feb; 23(5):1011-27. PubMed ID: 15585754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
    Shibuya M
    FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The origin of the endothelial cells: an evo-devo approach for the invertebrate/vertebrate transition of the circulatory system.
    Muñoz-Chápuli R; Carmona R; Guadix JA; Macías D; Pérez-Pomares JM
    Evol Dev; 2005; 7(4):351-8. PubMed ID: 15982372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of angiogenesis in vitro induced by VEGF-A and FGF-2 in two different human endothelial cultures - an all-in-one assay.
    Bahramsoltani M; De Spiegelaere W; Janczyk P; Hiebl B; Cornillie P; Plendl J
    Clin Hemorheol Microcirc; 2010; 46(2-3):189-202. PubMed ID: 21135494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mediator interactions in vasculogenesis and angiogenesis].
    Pavlov KA; Shchegolev AI; Dan VN; Sapelkin SV; Mishnev OD
    Angiol Sosud Khir; 2009; 15(2):31-5. PubMed ID: 19806936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do angiopoietins Tie in with vascular endothelial growth factors?
    Saharinen P; Bry M; Alitalo K
    Curr Opin Hematol; 2010 May; 17(3):198-205. PubMed ID: 20375888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.